RUA - Ticker AI Digest

Rua Life Sciences PLC
18.00 | Today -10.00%
Desk Snapshot GO VIP Login
Important AI Risk Notice

Charts, catalyst summaries, AI scores, forecasts and price context are AI-driven and can hallucinate, lag or miss market-changing information.

Not investment advice. Markets can move fast and any trade or allocation decision remains your responsibility.
AI can hallucinate. Summaries, rankings, forecasts and commentary can be wrong, incomplete or misleading.
AI-driven data only. Signals, dates, prices, sentiment and automation outputs may be delayed, estimated or stale.
Always verify externally. Confirm prices, filings, broker notes and trade setup details with independent sources before acting.
Mobile Command Deck
Rua Life Sciences PLC in one cleaner mobile flow.
Tap straight into the module you want. No sideways tab hunt, just a clean route into charts, news, Today’s AI, and the deeper desks.
RUA Data 2026-06-01 Preview Mode
Core Deck
Deep Dive Modules

Digested News

Today's Catalysts (RUA) 0
No same-day market news for RUA on 2026-06-01.
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 0
No items for this category on selected date.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 1
RUA 06:01
Rua Life Sciences PLC
Trading update for the 6-months ended 31/03/2026
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
RUA Life Sciences PLC reports a 6% revenue growth to £2.8 million for the 6-month period ending 31 March 2026, driven by a 32% increase in UK CDMO business and a 41% rise in biomaterials revenue. Gross margin slightly improved to 75%, and administrative costs decreased by 8%. The company expects to achieve EBITDA breakeven, with cash at £2.4 million. Key highlights include the spin-out of RUA Structural Heart, raising £3 million, and strategic developments in the CDMO and Abiss businesses. The company anticipates improved performance in the second half, with potential manufacturing contracts from development work and inventory normalization at Abiss.
Metric2025 (6 months ended 31/03/2025)2026 (6 months ended 31/03/2026)Change
Revenue£2.6 million£2.8 million+6%
UK CDMO Revenue£1.0 million£1.3 million+32%
Biomaterials Revenue£0.35 million£0.5 million+41%
Abiss Revenue£1.3 million£1.0 million-23%
Gross Margin74%75%+1%
Administrative Costs£2.5 million£2.3 million-8%
EBITDA (adjusted)-£0.4 million£0 million+£0.4 million
Cash ConsumedNot specified£0.9 millionN/A
Cash at Period EndNot specified£2.4 millionN/A
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 2
RUA 06:01
Rua Life Sciences PLC
Trading update for the 6-months ended 31/03/2026
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
RUA Life Sciences PLC reports a 6% revenue growth to £2.8 million for the 6-month period ending 31 March 2026, driven by a 32% increase in UK CDMO business and a 41% rise in biomaterials revenue. Gross margin slightly improved to 75%, and administrative costs decreased by 8%. The company expects to achieve EBITDA breakeven, with cash at £2.4 million. Key highlights include the spin-out of RUA Structural Heart, raising £3 million, and strategic developments in the CDMO and Abiss businesses. The company anticipates improved performance in the second half, with potential manufacturing contracts from development work and inventory normalization at Abiss.
Metric2025 (6 months ended 31/03/2025)2026 (6 months ended 31/03/2026)Change
Revenue£2.6 million£2.8 million+6%
UK CDMO Revenue£1.0 million£1.3 million+32%
Biomaterials Revenue£0.35 million£0.5 million+41%
Abiss Revenue£1.3 million£1.0 million-23%
Gross Margin74%75%+1%
Administrative Costs£2.5 million£2.3 million-8%
EBITDA (adjusted)-£0.4 million£0 million+£0.4 million
Cash ConsumedNot specified£0.9 millionN/A
Cash at Period EndNot specified£2.4 millionN/A
RUA 06:01
Rua Life Sciences PLC
Spinout and Completion of Financing of RSH

Today's AI

Today's AI Starts With News

Today’s AI opens with the latest catalyst tape for RUA.

No same-day headline has printed on 2026-06-01 yet, but the latest digestion still leads Today’s AI before the findings and blend stack below. Financial Forecastist remains wired into the blend.
Standby Tape Data 2026-06-01 Blend Lower Down
Read the alert tape first, then open Today’s AI findings. Use AI Expand on any card to open the AI explanation, results tables and financial forecast rows instantly.
0 Today
Front Of Desk
The live alert stack is quiet right now, but the latest digestion is still parked at the top before the findings and blend stack below.
06:01 Latest Tape Spinout and Completion of Financing of RSH
Single-Ticker Today's AI
RUA signal theatre built from scored market catalysts, automated AI forecasts, financial forecasting and live trigger logic.

This is the ticker-specific Today’s AI desk for Rua Life Sciences PLC. It compresses the live catalyst tape, bullish and bearish scoring, AI price forecasts, financial forecasting and trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI + Financial Blend Buy / Sell Trigger Engine Today's AI Findings
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full RUA Today’s AI cockpit.

Subscription turns this tab into a live signal desk with today’s news findings at the top, AI plus financial blend comparisons at the bottom, buy and sell trigger logic, and the full findings ledger behind every scored row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific Today’s AI stack, sentiment gauges, AI blend stage, and the full findings ledger for RUA on 2026-06-01.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
12.5M
Enterprise Value
4.8M
Public Float
81.7
Broker Target
50
Shares Out
62.1M
Long Interest
100
Short Interest
0
Exchange
LSE
Currency Code
GBX
ISIN
GB0033360586
Market
LSE - AIM
Sector
Pharmaceuticals and Biotechnology
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

News And Alerts First

The alert tape opens the door for RUA, and Financial Forecastist sits just below.

No same-day alert has printed on 2026-06-01 yet, but the latest digestion is pinned here first so the forecastist view below still opens with context instead of raw numbers.
Standby Alerts Data 2026-06-01 Forecastist Below
Read the alert tape first, then move into Financial Forecastist below. Use AI Expand on any catalyst card to open the AI explanation and results tables without losing the ticker context.
0 Alerts
Front Of Desk
The live alert stack is quiet right now, but the latest digestion is still parked at the top before the forecastist read below.
06:01 Latest Alert Spinout and Completion of Financing of RSH
Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
2009-01-01
Earnings Date
2026-01-25
Net Debt
-
Cash
-
EPS
-
Net Income
-145.3K
Revenue
4.5M
Enterprise Value
4.8M
Trailing PE
-
Forward PE
16.8919
Price Sales TTM
2.797
Price Book MRQ
1.7374
EV Revenue
2.4206
EV EBITDA
24.8281
Financial Forecastist

Mixed financial engine

Revenue is accelerating +85.3% against the prior comparable period. Net margin is expanding by 6.4 pts. Net debt is building +3850.0%.

Revenue +85.3% Net Income +46.5% FCF -100.2% Forward Rev 0
Mixed
Quarter Revenue
2.6M
+85.3%
vs prior comparable quarter
Net Margin
-24.3%
+6.4 pts
profitability pulse
Free Cash Flow
2.0K
-100.2%
cash conversion
Net Debt / EBITDA
-
+3850.0%
lower is cleaner
Revenue Engine

Latest quarter printed 2.6M with the top line pushing higher against the last comparable period.

Profit Stack

Net income landed at -630.0K and the margin profile is broadening. That usually tells us whether operating leverage is finally kicking in.

Balance-Sheet Pressure

Cash sits near - while net debt is -1.9M. The leverage stack is moving the wrong way.

Quarterly Revenue Runway

Actual revenue bars, consensus revenue where available, plus the terminal model path.

Profit And Cash Conversion

Net income and free cash flow moving together is usually what separates genuine improvement from noise.

Balance-Sheet Pressure

Cash, net debt and liquidity tell us whether the business is strengthening or just surviving.

Annual Power Curve

Longer-cycle revenue and net income help frame whether the company is compounding or rolling over.
Q4 2023
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q2 2024
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q3 2024
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q4 2024
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
FY 2026
Consensus
5.2M
Revenue Path
-0.01
EPS / Earnings
Growth cue -1.3%
FY 2027
Consensus
0
Revenue Path
-
EPS / Earnings
Growth cue -

Quarterly Statement Tape

Last 6 Quarters
Period Revenue Net Income FCF Net Debt
Q1 2026 2.6M -630.0K - -
Q3 2025 1.9M 484.7K 2.0K -1.9M
Q1 2025 2.6M -635.0K -23.0K -2.5M
Q3 2024 1.5M 636.0K -254.0K -2.4M
Q1 2024 1.4M -430.0K -458.0K -3.5M
Q3 2023 794.0K -1.0M -946.0K -48.0K

Annual Financial Power

Last 5 Years
Period Revenue Net Income EBITDA FCF
FY 2026 4.5M -145.3K -383.3K -
FY 2025 4.5M -145.3K -383.3K -298.0K
FY 2024 2.2M -1.4M -1.6M -1.4M
FY 2023 2.2M -2.0M -1.9M -1.6M
FY 2022 1.6M -2.1M -2.0M -3.3M

Structure DNA

Market Structure DNA

Institutional Trend Leader profile with trend runway open

Price is 89.7% through the 52-week range, +30.5% vs 50DMA and +42.4% vs 200DMA. 73.0% of the register is locked by institutions and insiders, leaving 27.0% free float. Capital rhythm reads no cadence with forward yield near 0.0% and payout around 0.0%.

Trend runway open Institutional gravity Moderate income rhythm As Of 2026-04-19
Institutional Trend Leader
Structure Score
69.2 / 100
Institutional Trend Leader
Trend Stack
+30.5% / +42.4%
vs 50DMA / 200DMA
52W Position
89.7%
auction position inside the yearly range
Ownership Lock
73.0%
22.4% institutions | 50.6% insiders
Pressure Pocket
27.0% free float
Vendor short-float fields were not supplied
Capital Rhythm
No cadence
Yield 0.0% | payout 0.0%
Trend Runway

Implied spot is 18.00 with the stock +30.5% vs 50DMA and +42.4% vs 200DMA. The tape is sitting 89.7% through the 52-week range, which frames the regime as trend runway open.

Ownership Register

Institutions hold about 22.4% and insiders about 50.6%, locking roughly 73.0% of the register and leaving 27.0% in free float. That reads as institutional gravity.

Pressure Pocket

The API did not return a usable short-float field for this ticker, so the pressure score leans more on float lock and crowding than a full short ledger.

Capital Rhythm

Dividend cadence reads no cadence with - event(s) in the last full year, a five-year average of -, and stability score 0.0/100. Forward yield sits near 0.0% while payout is around 0.0%.

Structure Score

One-glance gauge for the current market-structure regime.

Pillar Radar

Trend, ownership, pressure, and capital rhythm mapped on one wheel.

Position And Float Balance

Shows whether the stock is extended, tightly held, or carrying capital-return support.

Dividend Cadence Tape

Historical dividend-event counts help reveal how dependable the income rhythm has been.

Dividend Cadence Ledger

No cadence
Year Dividend Count Context
Dividend history has not been normalized yet.

Structure Facts

Live Snapshot
Implied Spot
18.00
derived from market cap / shares
52W High
18.87
upper auction edge
52W Low
10.42
lower auction edge
Beta
0.63
volatility character
Shares Out
62.1M
fully diluted count
Shares Float
50.7M
tradable register
Shares Short
0
borrowed stock
Short Ratio
0.0x
days-to-cover style read
Ex-Dividend
-
next ex-date not supplied
Dividend Pay
-
payment date not supplied
Last Split
1:10
2003-09-01

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
62060272
Public Hands
81.73
Institutions
-
Institutions As Of
-
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
2
Sale Director Dealing
0
Purchase TR1
0
Sale TR1
0
Broker Coverage Rows
0
Institution Holders Tracked
0
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

News And Alerts First

Start with the latest alert tape for RUA, then drop into AI Charts below.

No same-day headline has printed on 2026-06-01 yet, but the latest digestion is parked at the top before the chart workspace below so users can frame price, AI targets and structure from the latest tape.
Standby Tape Data 2026-06-01 AI Charts Below
Read the alert tape first, then move into AI Charts below. Use AI Expand on any catalyst card to open the AI explanation and results tables instantly.
0 Today
Catalyst Pulse
The live alert stack is quiet right now, but the latest digestion is still parked at the top before the chart read below.
06:01 Latest Tape Spinout and Completion of Financing of RSH
AI Charts Studio
RUA Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2026-06-01 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
Desk Snapshot Member Login
Indicators0
Technicals0
AI Forecast 515.22%
RSI Gauge
Price Change
AI Forecast